Results 351 to 360 of about 264,257 (370)
Some of the next articles are maybe not open access.
Treatment of diffuse large B-cell lymphomas
memo - Magazine of European Medical Oncology, 2009Diffuse large B-cell lymphoma represent 40% of all lymphoma. The development of dose-dense chemotherapeutic regimens and the application of the monoclonal CD20 antibody rituximab improve the prognosis significantly. Evaluation of clinical risk factors (age, stage, LDH, ECOG performance status, number of extranodal involvement) at initial diagnosis are ...
B, Gleissner, C, Zwick, M, Pfreundschuh
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2016
Systemic (or “non-CNS”) diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma accounting for approximately 30–40 % of all new lymphoma diagnoses in HIV-negative patients and 30–80 % in HIV-infected patients. Both plasmablastic lymphoma and primary CNS lymphoma are considered variants of DLBCL, but will be discussed in detail in separate ...
Stefan K. Barta +2 more
openaire +2 more sources
Systemic (or “non-CNS”) diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma accounting for approximately 30–40 % of all new lymphoma diagnoses in HIV-negative patients and 30–80 % in HIV-infected patients. Both plasmablastic lymphoma and primary CNS lymphoma are considered variants of DLBCL, but will be discussed in detail in separate ...
Stefan K. Barta +2 more
openaire +2 more sources
NHL (diffuse large B-cell lymphoma).
BMJ clinical evidence, 2016Non-Hodgkin's lymphoma (NHL) is the sixth most common cancer in the UK; 9443 new cases were diagnosed in the UK in 2002, and it caused 4418 UK deaths in 2003. Incidence rates show distinct geographical variation, with age-standardised incidence rates ranging from 17 per 100,000 in northern America to 4 per 100,000 in south-central Asia. NHL occurs more
Fiona, Kyle, Mark, Hill
openaire +3 more sources
Pathogenesis of diffuse large B cell lymphoma
International Journal of Hematology, 2010Substantial additional insight has been obtained in the past decade regarding the pathogenesis of diffuse large B cell lymphoma (DLBCL). Distinct subtypes of DLBCL have been defined by gene expression profiling (GEP) and they differ not only in GE profiles but also in the pattern of genetic abnormalities.
openaire +2 more sources
Pancreatic Diffuse Large B-Cell Lymphoma
Journal of Gastrointestinal Surgery, 2023Cuiping Zhang, Keping Tan, Jun Li
openaire +2 more sources
Endobronchial Diffuse Large B-cell Lymphoma
Archivos de Bronconeumología (English Edition), 2020Masahiro, Yamasaki +2 more
openaire +2 more sources
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Nature, 2000Ash A. Alizadeh +30 more
semanticscholar +1 more source